fluvastatin [orch, phsu]
Effect [qlco]
Clinical status [qlco]
Hepatic function [ortf]
Patients [podg]
ischaemic heart disease [dsyn]
Study [mnob]
included [ftcn]
IHD [dsyn]
Patients [podg]
Primary hypercholesterolaemia [dsyn]
Males [fndg]
Females [fndg]
Patients [podg]
Received [qlco]
Single [popg]
Daily Dose [qnco]
fluvastatin [orch, phsu]
mg% [qnco]
Evening [tmco]
weeks [tmco]
Drug effect [ftcn]
Assessed [acty]
Clinical status [qlco]
Lipid [lipd]
Spectrum [qnco]
Transport, NOS [celf]
Metabolic [ftcn]
Absorption [npop]
Secretory [celf]
Functions [ftcn]
Liver [bpoc]
IHD [dsyn]
Patients [podg]
Hypercholesterolaemia [dsyn]
Found [qnco]
To [qlco]
dysfunction [ftcn]
Hepatobiliary System [bdsy]
fluvastatin [orch, phsu]
treatment [ftcn]
Reduced [qlco]
Level [qlco]
Total Cholesterol [lbpr]
Cholesterol [bacs, strd]
Triglycerides [bacs, lipd]
cholesterol levels [lbpr]
Unchanged [fndg]
Atherogenesis [patf]
Lipoproteins [aapp, bacs]
Aggregation [ftcn]
Diminished [qnco]
Occurred [acty]
Hepatic Metabolism [ortf]
Bilirubin concentration [lbpr]
lowered [spco]
Serum Albumin [aapp]
Absorption [npop]
Secretory [celf]
function [phsf]
Hepatocytes [cell]
Normalized [resa]
Hepatic [blor]
System [ftcn]
Activated [acty]
fluvastatin [orch, phsu]
hepatic damage [patf]
Not [ftcn]
Reported [inpr]
Course [tmco]
month [tmco]
Follow-up [fndg]
